All News
Filter News
Found 808,490 articles
-
Lower-priced versions of Humalog® Mix75/25™ KwikPen® and Humalog® Junior KwikPen® now available
4/16/2020
Non-branded versions of Humalog® Mix75/25™ KwikPen® and Humalog® Junior KwikPen® are now available for order by U.S. pharmacies – adding to the broad suite of affordability options offered by Eli Lilly and Company.
-
InDex Pharmaceuticals Advances Cobitolimod Further Towards Phase III Following Successful Interactions With FDA and EMA
4/16/2020
InDex Pharmaceuticals Holding AB (publ) today announced that the company has received positive responses from FDA and EMA regarding phase III development of the company's TLR9 agonist cobitolimod, for the treatment of moderate to severe ulcerative colitis. The company is continuing its phase III preparations, including efforts to secure
-
Lack of Sleep and Chronic Stress Hurt the Immune System: Here’s How Vagus Nerve Stimulation Can Help During a Global Pandemic
4/16/2020
Stress is a part of life for many of us – especially now more than ever. Whether we are having trouble adjusting to working from home, caring for a sick relative or home-schooling children, it seems everyone is experiencing some form of stress during this global health crisis
-
Rite Aid Corporation Reports Fiscal 2020 Fourth Quarter and Full Year Results
4/16/2020
Rite Aid Corporation reported operating results for its fourth quarter and fiscal year ended February 29, 2020.
-
SUBLOCADE® Long-Term Safety Data Published in Journal of Clinical Psychopharmacology
4/16/2020
Indivior PLC announced the publication of long-term safety data for SUBLOCADE® injection, for subcutaneous use.
-
Cygnal Therapeutics Leader and Scientific Advisory Board Members Co-Author Paper in Cell Alongside Cancer Science Experts
4/16/2020
Cygnal Therapeutics today announced the publication of a new article in Cell, titled "Roadmap for the Emerging Field of Cancer Neuroscience." Jonathan Hurov, Ph.D., who serves as Cygnal's vice president of discovery biology and platforms, and multiple members of Cygnal's Scientific Advisory Board are co-authors on the paper, among other scientists.
-
Mallinckrodt to Report Earnings Results for First Quarter 2020
4/16/2020
Mallinckrodt plc, a global biopharmaceutical company, announced that it will report first quarter 2020 earnings results for the period ended March 27, 2020 on Tuesday, May 5, 2020.
-
Biohaven Enters Into Partnership With Medison Pharma To Distribute NURTEC™ ODT In Israel
4/16/2020
- Biohaven and Medison Pharma's partnership will bring NURTEC ODT, the first oral, quick-dissolve, calcitonin gene related peptide (CGRP) antagonist to patients in Israel - Registration in Israel based upon Biohaven's NURTEC ODT approval in the US
-
OneOncology Says Clinical Trial Accruals Increase in the Face of COVID-19
4/16/2020
OneOncology, the national partnership of independent community oncologists, said today that enrolling patients in clinical trials at its partner practices has slightly increased in March and April just as the COVID-19 pandemic hit our communities hardest.
-
CEVEC signs license agreement for the development and commercialization of exosomes for therapeutic use
4/16/2020
CEVEC Pharmaceuticals GmbH announced the signing of a license agreement with Evox Therapeutics, Ltd. for the development and commercialization of therapeutic exosomes using CEVEC’s proprietary CAP® technology.
-
RefleXion Raises $100 Million for Cancer Treatment Commercialization
4/16/2020
RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT) for all stages of cancer, today announced the close of a $100 million equity financing led by Public Sector Pension Investment Board (PSP Investments), one of Canada’s largest pension investment managers that focuses on long-term investments with partners demonstrating strong value orientation strategies.
-
AstraZeneca Donates 3 Million Surgical Masks to Direct Relief for Covid-19 Supply Needs in the US
4/16/2020
Direct Relief today announced a donation from AstraZeneca of 3 million surgical masks for US healthcare workers battling Covid-19.
-
Vyaire Announces HHS Contract to Produce 22,000 Ventilators
4/16/2020
Vyaire is one of seven companies awarded contracts to ramp up ventilator production
-
ADCES Launches Redesigned Member Community Platform ADCES Connect
4/16/2020
Revamped online member community gets update to align with rebranding of the association
-
Kemin Industries Partners with Pacific GeneTech to Bring Salmonella Vaccine to Poultry Industry
4/16/2020
Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, has signed an exclusive agreement with Pacific GeneTech, a biologics company that develops and commercializes next-generation vaccines for areas of high unmet or underserved needs in food safety and animal health, to license PGT's Salmonella vaccine for poultry.
-
Survey highlights vulnerabilities of chronically ill during COVID-19 pandemic
4/16/2020
Without adequate telehealth, individuals with chronic health issues face a difficult choice: receive in-person care and put themselves at risk of COVID-19, or deal with increased symptoms and worsening health.
-
VALBIOTIS Accelerates Its Pipeline Clinical Development in New Indications: Cardiovascular and Hepatic Steatosis Risk Reduction
4/16/2020
Launch of a Phase II clinical trial in the third quarter of 2020 evaluating the effect of TOTUM-070 in reducing LDL-cholesterol, a risk factor for cardiovascular disease, in mild to moderate hypercholesterolemic patients;
-
Immunomodulators Market: Increasing Incidences of Multiple Sclerosis to Drive Demand
4/16/2020
The global immunomodulators market is estimated to expand at a fast pace on account of several reasons including growing adoption of TNF alpha inhibitors and B cell inhibitors, rising adoption of monoclonal antibodies, advancements in diagnostic tools, presence of strong pipeline portfolio, and innovative technologies, states TMR Research in its latest report.
-
Portage Announces Cease Trade Order Revoked; Update on Impact of COVID-19 on Operations
4/16/2020
Portage Biotech Inc. wishes to announce that effective April 15, 2020, the Ontario Securities Commission revoked its Failure-to-File Cease Trade Order issued against the Company on August 2, 2019 and that trading of the Company's common shares on CSE is expected to resume shortly..
-
Tabula Rasa HealthCare® and CQuentia® Expand Partnership with COVID-19 Test Kit Distribution Agreement
4/16/2020
Tabula Rasa HealthCare®, Inc., a healthcare technology company advancing the field of medication safety, announced an expanded laboratory services agreement with CQuentia, a comprehensive analytics platform and molecular laboratory for personalized medicine.